J. Mehta, N. Rasouli, A. Sinha, and B. Molavi, Oxidative stress in diabetes: A mechanistic overview of its effects on atherogenesis and myocardial dysfunction, The International Journal of Biochemistry & Cell Biology, vol.38, issue.5-6, pp.794-803, 2006.
DOI : 10.1016/j.biocel.2005.12.008

J. Baynes, Role of Oxidative Stress in Development of Complications in Diabetes, Diabetes, vol.40, issue.4, pp.405-412, 1991.
DOI : 10.2337/diab.40.4.405

J. Witztum and D. Steinberg, Role of oxidized low density lipoprotein in atherogenesis., Journal of Clinical Investigation, vol.88, issue.6, pp.1785-1792, 1991.
DOI : 10.1172/JCI115499

A. Griesmacher, M. Kindhauser, and S. Andert, Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus, The American Journal of Medicine, vol.98, issue.5, pp.469-475, 1995.
DOI : 10.1016/S0002-9343(99)80347-7

N. Gopaul, E. Anggard, A. Mallet, D. Betteridge, S. Wolff et al., levels are elevated in individuals with non-insulin dependent diabetes mellitus, FEBS Letters, vol.23, issue.2, pp.225-229, 1995.
DOI : 10.1016/0014-5793(95)00649-T

G. Bellomo, E. Maggi, M. Poli, F. Agosta, P. Bollati et al., Autoantibodies Against Oxidatively Modified Low-Density Lipoproteins in NIDDM, Diabetes, vol.44, issue.1, pp.60-66, 1995.
DOI : 10.2337/diab.44.1.60

C. Napoli, F. Mancini, and G. Corso, A Simple and Rapid Purification Procedure Minimizes Spontaneous Oxidative Modifications of Low Density Lipoprotein and Lipoprotein (a), Journal of Biochemistry, vol.121, issue.6
DOI : 10.1093/oxfordjournals.jbchem.a021700

A. Zambon, I. Schmidt, U. Beisiegel, and J. Brunzell, Dimeric lipoprotein lipase is bound to triglyceride-rich plasma lipoproteins, J Lipid Res, vol.37, pp.2394-2404, 1996.

V. Pruneta, D. Autran, and G. Ponsin, Ex Vivo Measurement of Lipoprotein Lipase-Dependent Very Low Density Lipoprotein (VLDL)-Triglyceride Hydrolysis in Human VLDL: An Alternative to the Postheparin Assay of Lipoprotein Lipase Activity?, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.2, pp.797-803, 2001.
DOI : 10.1210/jc.86.2.797

O. Lowry, N. Rosebrough, A. Farr, and R. Randall, Protein measurement with the Folin phenol reagent, J Biol Chem, vol.193, pp.265-275, 1951.

T. Seppanen-laakso, I. Laakso, H. Vanhanen, K. Kiviranta, T. Lehtimaki et al., Major human plasma lipid classes determined by quantitative high-performance liquid chromatography, their variation and associations with phospholipid fatty acids, Journal of Chromatography B: Biomedical Sciences and Applications, vol.754, issue.2, pp.437-445, 2001.
DOI : 10.1016/S0378-4347(01)00031-7

R. Browne and D. Armstrong, HPLC analysis of lipid-derived polyunsaturated fatty acid peroxidation products in oxidatively modified human plasma, Clin Chem, vol.46, pp.829-836, 2000.

J. Therasse and F. Lemonnier, Determination of plasma lipoperoxides by high-performance liquid chromatography, Journal of Chromatography B: Biomedical Sciences and Applications, vol.413, pp.237-241, 1987.
DOI : 10.1016/0378-4347(87)80232-3

C. Calzada, L. Coulon, and D. Halimi, Glycoxidized Low-Density Lipoproteins and Low-Density Lipoproteins Isolated from Type 2 Diabetic Patients Activate Platelets via p38 Mitogen-Activated Protein Kinase, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.5, pp.1961-1964, 2007.
DOI : 10.1210/jc.2006-2045

URL : https://hal.archives-ouvertes.fr/inserm-00267256

S. Grundy, J. Cleeman, and S. Daniels, Diagnosis and management of the metabolic syndrome, Current Opinion in Cardiology, vol.21, issue.1, pp.2735-2752, 2005.
DOI : 10.1097/01.hco.0000200416.65370.a0

P. Wiesner, K. Leidl, A. Boettcher, G. Schmitz, and G. Liebisch, Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry, The Journal of Lipid Research, vol.50, issue.3, pp.574-585, 2009.
DOI : 10.1194/jlr.D800028-JLR200

A. Kuksis, J. Myher, K. Geher, W. Breckenridge, G. Jones et al., Lipid class and molecular species interrelationships among plasma lipoproteins of normolipemic subjects, Journal of Chromatography B: Biomedical Sciences and Applications, vol.224, issue.1, pp.1-23, 1981.
DOI : 10.1016/S0378-4347(00)80133-4

B. Engelmann, C. Brautigam, and J. Thiery, Plasmalogen Phospholipids as Potential Protectors Against Lipid Peroxidation of Low-Density Lipoproteins, Biochemical and Biophysical Research Communications, vol.204, issue.3, pp.1235-1242, 1994.
DOI : 10.1006/bbrc.1994.2595

H. Esterbauer, J. Gebicki, H. Puhl, and G. Jurgens, The role of lipid peroxidation and antioxidants in oxidative modification of LDL, Free Radical Biology and Medicine, vol.13, issue.4, pp.341-390, 1992.
DOI : 10.1016/0891-5849(92)90181-F

E. Barre, A more detailed fatty acid composition of human lipoprotein(a)???a comparison with low density lipoprotein, Chemistry and Physics of Lipids, vol.123, issue.1, pp.99-105, 2003.
DOI : 10.1016/S0009-3084(02)00167-6

H. Esterbauer, G. Jurgens, O. Quehenberger, and E. Koller, Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes, J Lipid Res, vol.28, pp.495-509, 1987.

L. Scheek, S. Wiseman, L. Tijburg, and A. Van-tol, Dialysis of isolated low density lipoprotein induces a loss of lipophilic antioxidants and increases the susceptibility to oxidation in vitro, Atherosclerosis, vol.117, issue.1, pp.139-144, 1995.
DOI : 10.1016/0021-9150(95)05555-B

J. Stephens, M. Khanolkar, and S. Bain, The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease, Atherosclerosis, vol.202, issue.2
DOI : 10.1016/j.atherosclerosis.2008.06.006

S. Mora, J. Otvos, R. Rosenson, A. Pradhan, J. Buring et al., Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women, Diabetes, vol.59, issue.5, pp.1153-1160
DOI : 10.2337/db09-1114

K. Feingold, C. Grunfeld, M. Pang, W. Doerrler, and R. Krauss, LDL subclass phenotypes and triglyceride metabolism in non-insulin- dependent diabetes, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.12, issue.12, pp.1496-1502, 1992.
DOI : 10.1161/01.ATV.12.12.1496

C. Packard, Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein, Biochemical Society Transactions, vol.31, issue.5, pp.1066-1069, 2003.
DOI : 10.1042/bst0311066

B. Verges, Lipid modification in type 2 diabetes: the role of LDL and HDL, Fundamental & Clinical Pharmacology, vol.49, issue.Suppl, pp.681-685, 2009.
DOI : 10.1111/j.1472-8206.2009.00739.x

D. Tribble, L. Holl, P. Wood, and R. Krauss, Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size, Atherosclerosis, vol.93, issue.3
DOI : 10.1016/0021-9150(92)90255-F

G. Jurgens, A. Fell, G. Ledinski, Q. Chen, and F. Paltauf, Delay of copper-catalyzed oxidation of low density lipoprotein by in vitro enrichment with choline or ethanolamine plasmalogens, Chemistry and Physics of Lipids, vol.77, issue.1, pp.25-31, 1995.
DOI : 10.1016/0009-3084(95)02451-N

N. Nagan and R. Zoeller, Plasmalogens: biosynthesis and functions, Progress in Lipid Research, vol.40, issue.3, pp.199-229, 2001.
DOI : 10.1016/S0163-7827(01)00003-0

E. Niki, Lipid peroxidation: Physiological levels and dual biological effects, Free Radical Biology and Medicine, vol.47, issue.5, pp.469-484, 2009.
DOI : 10.1016/j.freeradbiomed.2009.05.032

R. Mashima, K. Onodera, and Y. Yamamoto, Regioisomeric distribution of cholesteryl linoleate hydroperoxides and hydroxides in plasma from healthy humans provides evidence for free radical-mediated lipid peroxidation in vivo, J Lipid Res, vol.41, pp.109-115, 2000.

W. Liu, H. Yin, Y. Akazawa, Y. Yoshida, N. E. Porter et al., Ex vivo oxidation in tissue and plasma assays of hydroxyoctadecadienoates

R. Brenner, Hormonal modulation of ??6 and ??5 desaturases: case of diabetes, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.68, issue.2, pp.151-162, 2003.
DOI : 10.1016/S0952-3278(02)00265-X

M. Schneider, B. Verges, and A. Klein, Alterations in Plasma Vitamin E Distribution in Type 2 Diabetic Patients With Elevated Plasma Phospholipid Transfer Protein Activity, Diabetes, vol.53, issue.10, pp.2633-2639, 2004.
DOI : 10.2337/diabetes.53.10.2633